RedHill Biopharma reported $-1.54M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
Cara Therapeutics USD -6.8M 1.9M Mar/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
Cronos Group USD 18.14M 30.52M Mar/2026
RedHill Biopharma USD -1.54M 12M Jun/2024